ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.275
      -0.01%
      Bitcoin
      67,820.18
      -0.49%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. MiNK Therapeutics Inc (INKT)

      7. MiNK Therapeutics Inc (INKT) Financials

      MiNK Therapeutics Inc

      MiNK Therapeutics Inc (INKT)

      NASDAQ
      0.88
      -0.08
      (-8.33%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      0.8603
      -0.0197
      (-2.24%)
      After Hours: 7:39PM
      Delayed by 15 minutes

      MiNK Therapeutics Inc Financial Summary

      The current INKT market cap is 29.88M. The company's latest EPS is USD -0.6467 and P/E is -1.36.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -5.85M-6.34M-5.22M-5.5M-3.83M
      Net Income -5.69M-6.2M-5.12M-5.46M-3.81M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.2M0000
      Operating Income -22.28M-14.64M-28.36M-30.95M-22.92M
      Net Income -23.8M-16.24M-30.21M-27.99M-22.46M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 16.59M12.11M7.46M4.55M6.89M
      Total Liabilities 21.07M21.61M21.04M22.61M27.19M
      Total Equity -4.48M-9.5M-13.58M-18.06M-20.3M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.31M4.56M40.24M21.47M4.55M
      Total Liabilities 37.64M58.43M16.47M21.87M22.61M
      Total Equity -36.33M-53.87M23.78M-401k-18.06M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.37M-8.52M-12.73M-15.76M-2.54M
      Investing -14k-51k-74k-74k N/A
      Financing -335k-410k-408k-407k5.01M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -14.94M-8.34M-12.83M-18.87M-15.76M
      Investing -426k-95k-249k-250k-74k
      Financing 11.44M11.11M49.26M-155k-407k

      Stats and Ratios

      Market Cap 29.88M
      Price to Earnings Ratio -1.36
      Price to Sales Ratio 0
      Price to Cash Ratio 9.07
      Price to Book Ratio -1.69
      Dividend Yield -

      Share Statistics

      Shares Outstanding 34.73M
      Average Volume (1 week) 128.01k
      Average Volume (1 Month) 71.59k
      52 Week Change -53.99%
      52 Week High 1.96
      52 Week Low 0.75
      Spread (Intraday) 0.79 (47.86%)

      Company Info

      Company Name MiNK Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://minktherapeutics.com
      Industry biological pds,ex diagnstics (2836)